You've likely noticed that we have been talking a lot about Intellectual Property issues within the dietary supplements industry lately, not just in the United States, but abroad as well. We feel it's an important conversation to keep having, because it directly impacts innovation, which is what drives our industry's growth. For our industry to be sustainable as the market matures, the historical practice of IP infringement must stop. While we remain committed to this undertaking, we will have no choice except to take legal recourse to those who blatantly infringe.
Dr. Majeed spoke on Curcumin first, and highlighted the following:
By the scientific and clinical evidence that is being received currently, the year 2014 is going to be the year of Curcumin C3 Complex. This is the time to decide how we, as an industry, are going to handle the expansion of consumer demand for Curcumin, which will have a significant impact on how large the market grows and the longevity of that market. Quite simply, we want to ensure that consumers are using products that work, consistently.
